Splenocyte apoptosis in plasmodium berghei ANKA infection: Possible role of TNF-α and TGF-β

Parasite Immunology

Volumn 35, Issue 2, 2013, Pages 73-90

  Keswani, T ^a   Bhattacharyya, A ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Apoptosis; Plasmodium berghei ANKA; Spleen; Transforming growth factor ; Tumour necrosis factor

Indexed keywords

CASPASE 3; CASPASE 8; FAS LIGAND; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL CYCLE CHECKPOINT; CELL CYCLE G0 PHASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; MALE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMODIUM BERGHEI ANKA INFECTION; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SPLEEN CELL; UPREGULATION;

ANIMALS; APOPTOSIS; BENZAMIDES; CELL SURVIVAL; DIOXOLES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCYTOCHEMISTRY; MALARIA; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; PARASITEMIA; PENTOXIFYLLINE; PLASMODIUM BERGHEI; SPLEEN; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

PLASMODIUM BERGHEI;

EID: 84872343607     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12005     Document Type: Article

References (88)

1. Miller LH, Baruch DI, Marsh K & Doumbo OK. The pathogenic basis of malaria. Nature 2002; 415: 673-679.
2. Yanez DM, Manning DD, Cooley AJ, Weidanz WP & Van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 1996; 157: 1620-1624.
3. Griffith JW, O'Connor C, Bernard K, Town T, Goldstein DR & Bucala R. Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis 2007; 19: 1553-1564.
4. Amani V, Boubou MI, Pied S, et al. Cloned Lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun 1998; 66: 4093-4099.
5. Ramakrishnan SP, Bruce-Chwatt LJ, Prakash S, et al. Selection of a strain of albino mice refractory to Plasmodium berghei infection. Bull Wld Hlth Org 1964; 31: 393-397.
6. Carvalho LJM, Maria FFC, Claudio TDR, Marcelo PM & Henrique LL. Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malaria J 2007; 6: 59.
7. Li C, Seixas E & Langhorne J. Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med Microbiol Immunol 2001; 189: 115-126.
8. Good MF, Xu H, Wykes M & Engwerda CR. Development and regulation of cell mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 2005; 23: 69-99.
9. + T cells undergo extensive apoptosis during a Plasmodium chabaudi AS infection. Parasite Immunol 2001; 23: 617-626.
10. Martins YC, Smith MJ & Pelajo-Machado M. Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA. Int J Exp Pathol 2009; 90: 119-130.
11. Faucher JF, Creantor C, Hustache-Mathieu L, Chirouze C, Millon L & Hoen B. A typical course of falciparum malaria in an asplenic patient. Presse Med 2006; 35: 793-795.
12. Oster CN, Koontz LC & Wyler DJ. Malaria in asplenic mice: effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg 1980; 29: 1138-1142.
13. Eling WM. Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun 1980; 30: 635-641.
14. + regulatory T cells during infection are directly associated with level of circulating parasites. PLoS ONE 2010; 5: e9623.
15. Del PortilloHA, Ferrer M, Brugat Th, Martin-Jaular L, Langhorne J & Lacerda Marcus VG. The role of the spleen in malaria. Cell Microbiol 2012; 14: 343-355.
16. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
17. Touré-Baldé A, Sarthou JL, Aribot G, et al. Plasmodium falciparum induces apoptosis in human mononuclear cells. Infect Immun 1996; 64: 744-750.
18. Carvalho LJM, Ferreira-da-Cruz MF, Pelajo-Machado M, Daniel-Ribeiro CT & Lenzi HL. Plasmodium berghei ANKA infection induces thymocyte apoptosis and thymocyte depletion in CBA mice. Mem Inst Oswaldo Cruz 2006; 101: 523-528.
19. Kapoor G, Bagai U & Banyal HS. Plasmodium berghei induces apoptotic changes in splenic and peripheral blood cells. Trop Biomed 2011; 28: 119-124.
20. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995; 13: 513-543.
21. Bate CA, Taverne J & Playfair JHL. Soluble malarial antigens are toxic and induce the production of tumor necrosis factor in vivo. Immunol 1989; 66: 600-605.
22. Schofield L & Hackett F. Signal transduction in host cells by a glycosyl phosphatidylinositol toxin of malaria parasites. J Exp Med 1993; 177: 145-153.
23. Bellone G, Aste-Amezaga M, Trinchieri G & Rodeck U. Regulation of NK cell functions by TGF-β1. J Immunol 1995; 155: 1066-1073.
24. Kwiatkowski D, Hill AVS & Sambou I. TNF-α concentration in fatal, nonfatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 1990; 336: 1201-1204.
25. Lehman LG, Vu-Quoc B, Carlson J & Kremsner PG. Plasmodium falciparum: inhibition of erythrocyte rosette formation and detachment of rosettes by pentoxifylline. Trans R Soc Trop Med Hyg 1997; 91: 74-75.
26. Kremsner PG, Grundmann H, Neifer S, et al. Pentoxifylline prevents murine cerebral malaria. J Infect Dis 1991; 164: 605-608.
27. Santos-Neto L, Muniz-Junqueira MI, Brandt MC & Tosta CE. Has pentoxifylline a place in the therapy of malaria? Rev Soc Brasil Med Trop 1992; 25(Suppl. II): 66-67.
28. Ward A & Clissold SP. Pentoxifylline - A review of its pharmacodynamics and pharmacokinetic properties and its therapeutic efficacy. Drugs 1987; 34: 50-97.
29. Samlaska MCP & Winfield MC. Pentoxifylline. J Am Acad Dermatol 1994; 30: 603-617.
30. Gupta M, George A, Sen R, Rath S, Durdik JM & Bal V. Presence of pentoxifylline during T cell priming increases clonal frequencies in secondary proliferative responses and inhibits apoptosis. J Immunol 1999; 162: 689-695.
31. Mensah-Brown EP, Stosic Grujicic S, Maksimovic D, Jasima A, Shahin A & Lukic ML. Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol Immunol 2002; 38: 941-946.
32. Omer FM & Riley EM. Transforming growth factor β production is inversely correlated with severity of murine malaria infection. J Exp Med 1998; 188: 39-48.
33. Day NPJ, Hien TT, Schollaardt T, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 1999; 180: 1288-1297.
34. Perkins D, Weinberg J & Kremsner P. Reduced interleukin-12 and transforming growth factor-b1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis 2000; 182: 988-992.
35. May J, Lell B, Luty A, Meyer C & Kremsner P. Plasma interleukin-10: tumor necrosis factor (TNF)-a ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 2000; 182: 1570-1573.
36. Wei W, Bing M, Heng-yu L, et al. Biphasic effects of selective inhibition of Transforming growth factor-β1 Activin receptor like kinase on LPS induced lung injury. Shock 2010; 33: 218-224.
37. Inman GJ, Nicola′s FJ, Callahan JF, et al. SB 431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor Y like kinase (ALK) receptors ALK4, ALK5 and ALK7. Mol Pharmacol 2002; 62: 65-74.
38. Waghabi MC, Keramidas M, Calvet CM, et al. SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion. Antimicrob Agents Chemother 2007; 51: 2905-2910.
39. Helmby H, Jonsson G & Troye-Blomberg M. Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun 2000; 68: 1485-1490.
40. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999; 33: 29-55.
41. Bretz JD, Arscott PL, Myc A & Barker JR Jr. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 1999; 274: 25433-25438.
42. Dybedal I, Guan F, Borge OJ, et al. Transforming growth factor-β1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood 1997; 90: 3395-3403.
43. Lee SJ, Zhou T, Choi C, Wang Z & Benveniste EN. Differential regulation and function of Fas expression on glial cells. J Immunol 2000; 164: 1277-1285.
44. Schlapbach R, Spanaus KS, Malipiero U, et al. TGF-β induces the expression of the FLICE-inhibitorynprotein and inhibits Fas-mediated apoptosis of microglia. Eur J Immunol 2000; 30: 3680-3688.
45. Santiago B, Galindo M, Palao G & Pablos JL. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide. J Immunol 2004; 172: 560-566.
46. Oakley MS, Majam V, Mahajan B, et al. (2009) Pathogenic roles of CD14, Galectin-3, and OX40 during experimental cerebral malaria in mice. PLoS ONE 4: e6793.
47. Hunt NH & Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003; 24: 491-499.
48. Neill AL & Hunt NH. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitol 1992; 105: 165-175.
49. Green TP, Johnson DE, Marchessault RP & Gatto CW. Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J Lab Clin Med 1988; 111: 73-183.
50. Penet MF, Abou-Hamdan M, Colte N, et al. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc Natl Acad Sci USA 2008; 105: 1321-1326.
51. Mitra S, Keswani T, Dey M, et al. Copper induced immunotoxicity involves cell cycle arrest and cell death in the spleen and thymus. Toxicol 2012; 293: 78-88.
52. Pennington RJ. Biochemistry of dystrophic muscle: mitochondrial succinate tetrazolium reductase and adenosine triphosphatase. Biochem J 1961; 80: 649-654.
53. Kruidering M & Evan GI. Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life 2000; 50: 85-90.
54. Bogdan C, Paik J, Vodovotz Y & Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 1992; 267: 23301-23308.
55. Krücken J, Mehnert LI & Dkhil MA. Massive destruction of malaria-parasited red blood cells despite spleen closure. Infect Immun 2005; 73: 6390-6398.
56. Riccio EK, Junior IN, Riccio LR, et al. Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks. Parasitol Res 2003; 90: 9-18.
57. Ahvazi BC, Jacobs P & Stevenson MM. Role of macrophage derived nitric oxide in suppression of lymphocyte proliferation during blood stage malaria. J Leukoc Biol 1995; 58: 23-31.
58. Villegas-Mendez A, de Souza JB & Murungi L. Heterogeneous and tissue-specific regulation of Plasmodium effector T cell responses by IFN- g during berghei ANKA infection. J Immunol 2011; 187: 2885-2897.
59. Hirunpetcharat C & Good MF. Deletion of Plasmodium berghei-specific CD41 T cells adoptively transferred into recipient mice after challenge with homologous parasite. Proc Natl Acad Sci USA 1998; 95: 1715-1720.
60. Wipasa J, Okell L, Sakkhachornphop S, et al. Short-lived IFN-c effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog 2011; 7: e1001281.
61. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M & Yodoi J. Redox control of cell death. Antioxid Redox Signal 2002; 4: 405-414.
62. Kern P, Dietrich M, Hemmer C & Wellinghausen N. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. Infect Immun 2000; 68: 3061-3063.
63. Molyneux ME, Engelmann H, Taylor TE, et al. Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine 1993; 5: 604-609.
64. Matsumoto J, Kawai S, Terao K, et al. Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection. Infect Immun 2000; 68: 1183-1188.
65. Juo P, Kuo CJ, Yuan J & Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998; 8: 1001-1008.
66. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470.
67. Sullivan GW. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function with pentoxifylline. Infect Immun 1988; 56: 1722-1729.
68. Semmler J, Gebert U, Eisenhut T, et al. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunol 1993; 78: 520-525.
69. Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A & Formisano S. Inhibition of IgEmediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem Pharmacol 1987; 36: 13-20.
70. Renz H, Gong JH, Schmidt A, Nain M & Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1998; 141: 2388-2393.
71. Luo M, Jones SM, Phare SM, Coffey MJ, Peters-Golden M & Brock TG. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J Biol Chem 2004; 279: 41512.
72. Seiffge D. Effect of pentoxifylline on red cell aggregation. Med Sci 1982; 8: 727.
73. Omer FM, deSouza JB & Riley EM. Differential induction of TGF-β regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J Immunol 2003; 171: 5430-5436.
74. Engwerda CR, Mynott T, Sawhney S, De SouzaJ, Bickle Q & Kaye P. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J Exp Med 2002; 195: 1371.
75. De Souza JB, Williamson KH, Otani T & Playfair JHL. Early gamma interferon responses in lethal and nonlethal murine blood stage malaria. Infect Immun 1997; 65: 1593-1598.
76. Clark IA, Ilschner S, MacMicking JD & Cowden WB. TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunol Lett 1990; 25: 195-198.
77. Che LM, Niu YX, Li HZ & Chen XN. Role of TNF-alpha and ICAM-1 in pathogenesis of cerebral malaria. Chin J Parasitol Parasitic Dis 2000; 18: 138-140.
78. Grau GE, Fajardo LF, Piguet PF, et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237: 1210-1212.
79. Rudin W, Eugster HP, Bordmann G, et al. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 upregulation and T helper type 1 response. Am J Pathol 1997; 150: 257-266.
80. Van Hensbroek MB, Palmer A, Onyiorah E, et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 1996; 174: 1091-1097.
81. Kwiatkowski D, Molyneux ME, Stepkens S, et al. Anti-TNF therapy inhibits fever in cerebral malaria. Quarterly J Med 1993; 86: 91-98.
82. Assosian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type b transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84: 6020-6024.
83. Genestier L, Kasibhatla S, Brunner T & Green DR. Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med 1999; 189: 231-239.
84. Park SM, Kim S, Cho JS, et al. TGF-beta inhibits Fas-mediated apoptosis of a follicular dendritic cell line by down-regulating the expression of Fas and caspase-8: counteracting role of TGF-beta on TNF sensitization of Fas-mediated apoptosis. J Immunol 2005; 174: 6169-6175.
85. Chang WL, Jones SP, Lefer DJ, et al. CD8 (+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect Immun 2001; 69: 7341-7348.
86. Berendt AR, Tumer GD & Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today 1994; 10: 412-414.
87. Engwerda CR, Beattie L & Amante FH. The importance of the spleen in malaria. Trends Parasitol 2005; 21: 75-80.
88. Newton CR & Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998; 79: 1-53.